Acer Therapeutics Q3 EPS $(0.52) Down From $(0.43) YoY

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.

Benzinga · 11/13/2019 21:18

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.